European Companies Search Engine
vTv Therapeutics Inc., High Point, United States
If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.
The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .
Add to dossier (if available):
Name
Identification
Address
Corporate purpose
VTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis … Show more
Network
Annual report
Publications
The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.
The visualizations for "vTv Therapeutics Inc., High Point, United States"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.